Buy 4-AcO-MET for sale online from USA vendor
Table of Contents:
-
Introduction
- Definition and Overview
- Chemical Structure and Classification
-
Chemistry
- Molecular Composition and Structure
- Pharmacology
- Hydrolysis and Metabolic Fate
-
Dosage
- Threshold
- Light
- Common
- Strong
- Heavy
-
Subjective Effects
- Disclaimer
- Unpredictability and Dose-Dependency
- Subjective Effect Categories
- Visual Effects
- Cognitive Effects
- Somatic Effects
- Auditory Effects
- Conclusion
-
Physical Effects
- Sedation
- Spontaneous Physical Sensations
- Changes in Felt Bodily Form
- Muscle Contractions and Relaxation
- Excessive Yawning and Other Effects
-
Visual Effects
- Enhancements and Distortions
- Drifting and Other Distortions
- Visual Geometry
- Hallucinatory States
-
Cognitive Effects
- Relaxing Yet Fast-Paced Cognitive Style
- Immersive and Thought-Provoking
-
Toxicity, Tolerance, and Addiction Potential
- Limited Scientific Study
- Harm Reduction
- Tolerance and Addiction
- Dangerous Interactions
-
Legal Status
- Overview and Disclaimer
- Country-Specific Regulations
- Germany
- Switzerland
- United Kingdom
- United States
Introduction to 4-AcO-MET
4-Acetoxy-N-methyl-N-ethyltryptamine, commonly known as 4-AcO-MET, Metacetin, or Azomet, belongs to the tryptamine class of novel psychedelic substances. Within this group, substances induce psychedelic effects reminiscent of psilocybin when ingested. Structurally, 4-AcO-MET bears resemblance to other psychedelic tryptamines such as 4-AcO-DMT, 4-AcO-DET, and 4-AcO-MiPT.
Structural Relationship with 4-HO-MET
A noteworthy feature of 4-AcO-MET is its structural similarity to 4-HO-MET, leading to the hypothesis that it may function as a prodrug for the latter. The substance has been identified sporadically in pressed pills circulating in northern Switzerland, often being sold under the street names "Acomet" or "Azomet."
Limited Data and Research
Despite its intriguing properties, there is a scarcity of information regarding the pharmacological attributes, metabolism, and toxicity of 4-AcO-MET. Its historical usage among humans is minimal, and it is primarily marketed as a research chemical available for purchase online.
Harm Reduction Practices
Due to the lack of comprehensive data, caution is strongly recommended for those considering the use of 4-AcO-MET. As a substance sold online for research purposes, it falls within the realm of research chemicals. Users are advised to adopt rigorous harm reduction practices to mitigate potential risks associated with its consumption.
Chemistry of 4-AcO-MET
Molecular Composition and Structure
4-AcO-MET, scientifically termed 4-Acetoxy-N-methyl-N-ethyltryptamine, stands as a synthetic indole alkaloid within the tryptamine class. The tryptamine molecules share a foundational structure, featuring a bicyclic indole heterocycle connected at R3 to an amino group through an ethyl side chain. Specifically, 4-AcO-MET presents an acetoxy (AcO) functional group CH3COO− at the R4 position of its indole heterocycle. Additionally, it incorporates a methyl group and an ethyl chain bound to the terminal amine RN, defining its tryptamine backbone. Notably, 4-AcO-MET serves as the acetate ester analog of 4-HO-MET and the N-substituted ethyl homolog of 4-AcO-DMT.
Pharmacological Insights
Rapid Hydrolysis and Metabolism
A prevailing hypothesis suggests that 4-AcO-MET undergoes rapid hydrolysis into the free phenolic 4-HO-MET, catalyzed by serum esterases. Unfortunately, the dearth of human studies on the metabolic fate of this substance leaves a critical gap in understanding its physiological journey.
5-HT2A Receptor Interaction
The psychedelic effects attributed to 4-AcO-MET are thought to arise from its activity at the 5-HT2A receptor, functioning as a partial agonist. However, the intricate nature of these receptor interactions and their manifestation in the psychedelic experience remains a topic of ongoing exploration.
Parallel with 4-HO-MET
A parallel can be drawn with the hypothesis that 4-AcO-MET, akin to 4-AcO-DMT, may be swiftly hydrolyzed into 4-HO-MET. This proposed metabolic transformation could elucidate the observed similarities in subjective effects between the two compounds. The analogy extends to the conversion of 4-AcO-DMT to 4-HO-DMT during first-pass metabolism and subsequent liver passes.
In conclusion, the chemistry of 4-AcO-MET unveils a complex interplay of molecular structures and potential metabolic pathways. The conjecture surrounding its conversion to 4-HO-MET and the involvement of 5-HT2A receptors paves the way for future research endeavors to unravel the intricacies of this intriguing psychedelic tryptamine.
Navigating 4-AcO-MET Dosages
Understanding Threshold Effects
The dosage spectrum of 4-AcO-MET, a synthetic indole alkaloid within the tryptamine class, delineates distinct thresholds for various experiential intensities.
Dosage Guidelines
Light Experience (10 - 20 mg)
At this dosage range, users can anticipate a light psychedelic encounter with the effects of 4-AcO-MET manifesting subtly. This range is ideal for those seeking a gentle introduction to its psychoactive properties.
Common Territory (20 - 30 mg)
Stepping into the common dosage zone, users may experience more pronounced psychedelic effects. This range is often chosen by individuals seeking a moderate yet well-defined psychedelic experience, striking a balance between intensity and manageability.
Strong Effects (30 - 50 mg)
The strong dosage range of 30 to 50 mg ushers in a more robust and immersive psychedelic encounter. Users in this territory should be prepared for intensified effects, potentially delving deeper into the realms of altered perception and profound introspection.
Heavy Exploration (50 mg +)
Venturing into the heavy dosage category, users surpass the 50 mg threshold, signaling a potent and potentially overwhelming psychedelic experience. Extreme caution is advised at this level, as the effects can be intense and challenging, requiring a seasoned and prepared mindset.
In summary, the dosages of 4-AcO-MET span a spectrum from threshold to heavy, offering users the flexibility to tailor their experiences based on their desired intensity. However, adherence to these dosage guidelines is crucial for ensuring a safe and enjoyable exploration of the psychedelic effects associated with 4-AcO-MET.
Subjective Effects of 4-AcO-MET
Introduction and Disclaimers
Before delving into the subjective effects of 4-AcO-MET, it's essential to acknowledge the source of information – the Subjective Effect Index (SEI). The SEI is derived from anecdotal user reports and personal analyses contributed by PsychonautWiki contributors. However, users should approach these findings with a healthy dose of skepticism.
Unpredictability and Dose-Dependency
The effects listed below are not guaranteed to occur predictably or reliably, as individual responses can vary. Higher doses, though, are more likely to induce the full spectrum of effects associated with 4-AcO-MET. It's crucial to recognize that, as doses increase, the likelihood of adverse effects also rises. These adverse effects can range from addiction to severe injury or, in extreme cases, death.
Subjective Effect Categories
Visual Effects
Enhancements
- Vibrant colors
- Visual distortions
Distortions
- Tracers
- Afterimages
Cognitive Effects
Introspection
- Deep self-reflection
- Enhanced introspective thoughts
Conceptual Thinking
- Altered perspectives
- Novel ideas
Somatic Effects
Physical Discomfort
- Nausea
- Body tension
Sedation
- Calmness
- Relaxation
Auditory Effects
Distortions
- Altered perception of sound
- Auditory hallucinations
Emotional Effects
Euphoria
- Heightened sense of happiness
- Emotional warmth
Anxiety
- Nervousness
- Restlessness
Conclusion
In conclusion, the subjective effects of 4-AcO-MET encompass a diverse array of experiences, spanning visual, cognitive, somatic, auditory, and emotional realms. However, users should approach these effects with caution, considering the inherent unpredictability and dose-dependent nature of 4-AcO-MET. The disclaimer serves as a reminder of the potential risks associated with higher doses, emphasizing the importance of responsible usage and informed decision-making.
Physical Effects
Sedation
Considered relaxing and mildly sedating, 4-AcO-MET induces a sense of tranquility often accompanied by compulsive yawning. Notably, its sedative properties are deemed less potent than those of related compounds like psilocin and 4-AcO-DMT.
Spontaneous Physical Sensations
The "body high" associated with 4-AcO-MET is characterized by a pleasurable, warm, and all-encompassing tingling sensation. This sensation steadily rises with onset, reaching its peak during the experience.
Changes in Felt Bodily Form
Users may experience alterations in bodily form, accompanied by a sense of warmth. This phenomenon occurs typically around or after the peak, with users reporting a feeling of being physically connected or conjoined with other objects, evoking comfort or, in some cases, bodily tension.
Muscle Contractions and Relaxation
Transient and benign muscle contractions are noted, distinguishing 4-AcO-MET from other tryptamines, phenethylamines, and lysergamides. Muscle relaxation is also observed.
Excessive Yawning and Other Effects
Unique to substances like psilocin and related tryptamines, excessive yawning is pronounced. Additional effects include watery eyes, olfactory hallucinations, pupil dilation, runny nose, increased salivation, teeth grinding (of lesser intensity compared to substances like MDMA), and nausea.
Visual Effects
Enhancements and Distortions
- Enhancements: Vibrant colors, visual distortions.
- Distortions: Tracers, afterimages.
Drifting and Other Distortions
- Drifting: Highly detailed, cartoon-like, slow and smooth motion.
- After Images, Colour Shifting, Environmental Patterning, Scenery Slicing, Symmetrical Texture Repetition, Tracers.
Visual Geometry
The visual geometry of 4-AcO-MET shares similarities with psilocin, 4-AcO-DMT, and 4-HO-MiPT. It features intricate, abstract, synthetic, and organic elements, with strong "synthetic" digital undertones comparable to 2C-B. Higher dosages may lead to level 8A visual geometry.
Hallucinatory States
4-AcO-MET induces a range of high-level hallucinatory states, including transformations and internal hallucinations. These experiences often occur in dark environments at appropriate dosages.
Cognitive Effects
Relaxing Yet Fast-Paced Cognitive Style
The cognitive effects of 4-AcO-MET are often described as somewhat relaxing but fast-paced, akin to psychedelics like LSD or 2C-B. Notable cognitive effects include analysis enhancement, conceptual thinking, delusion, ego death, emotion enhancement, and perception of interdependent opposites.
Immersive and Thought-Provoking
Other cognitive effects include increased music appreciation, memory suppression, novelty enhancement, thought acceleration, thought connectivity, thought loops, time distortion, unity, interconnectedness, wakefulness, brain zaps, and auditory effects.
Toxicity, Tolerance, and Addiction Potential
Limited Scientific Study
The toxicity and long-term health effects of recreational 4-AcO-MET use lack comprehensive scientific study, given its status as a research chemical with minimal human usage history.
Harm Reduction
Anecdotal evidence suggests no negative health effects at low to moderate doses. However, harm reduction practices are strongly recommended, and independent research should precede any substance combination.
Tolerance and Addiction
4-AcO-MET is not habit-forming and may lead to decreased desire with use. Immediate tolerance builds after ingestion, taking about 3 days to reduce by half and 7 days to return to baseline. Cross-tolerance with other psychedelics is noted.
Dangerous Interactions
Cautionary Notes
Several potential dangerous interactions are highlighted, including combining 4-AcO-MET with lithium, cannabis, stimulants, and tramadol. Independent research is essential to ensure the safety of substance combinations.
In conclusion, the comprehensive overview sheds light on the multifaceted effects of 4-AcO-MET, emphasizing the importance of responsible usage, harm reduction, and informed decision-making.
Legal Status of 4-AcO-MET
Overview and Disclaimer
This legal status section provides a snapshot of the regulatory framework surrounding 4-AcO-MET, acknowledging that the information presented may be incomplete or subject to change. Readers are encouraged to contribute to its expansion for accuracy.
Country-Specific Regulations
Germany
As of July 18, 2019, 4-AcO-MET is regulated under the NpSG (New Psychoactive Substances Act) in Germany. The act prohibits production and import with the intent to place it on the market, administration to others, placing it on the market, and trading. While possession is illegal, it is not punishable. The legislative perspective considers the possibility of ordering 4-AcO-MET as potentially punishable, akin to an incitement to place it on the market.
Switzerland
In Switzerland, 4-AcO-MET falls under controlled substances, specifically listed under Verzeichnis E.
United Kingdom
The United Kingdom classifies 4-AcO-MET as a Class A drug. This designation stems from its status as an ester of 4-HO-MET, itself a Class A drug due to the tryptamine catch-all clause.
United States
In the United States, 4-AcO-MET is currently unscheduled. However, it may be considered an analogue of psilocin (4-HO-DMT), which is a Schedule I drug under the Controlled Substances Act. Consequently, selling it for human consumption or using it for illicit non-medical or industrial purposes could lead to prosecution under the Federal Analogue Act.
In conclusion, the legal status of 4-AcO-MET varies across countries, with Germany and the United Kingdom imposing stricter regulations compared to the United States, where it remains unscheduled but subject to potential prosecution under specific circumstances. Users and researchers should stay informed about legal developments to ensure compliance with relevant regulations.
FAQ:
Q1: What is 4-AcO-MET?
A1: 4-AcO-MET is a synthetic indole alkaloid classified under the tryptamine class, known for its psychedelic effects similar to psilocybin.
Q2: How is 4-AcO-MET related to other substances?
A2: Structurally related to 4-HO-MET, it is theorized to act as a prodrug. It shares connections with psychedelic tryptamines like 4-AcO-DMT, 4-AcO-DET, and 4-AcO-MiPT.
Q3: What are the recommended dosages?
A3: Dosages range from 5 mg (threshold) to 50 mg and beyond (heavy), with effects intensifying at higher doses. Users are advised to adhere to harm reduction practices.
Q4: What are the subjective effects of 4-AcO-MET?
A4: Subjective effects encompass visual, cognitive, somatic, auditory, and emotional realms. However, individual responses vary, and caution is urged due to potential unpredictability.
Q5: What are the legal implications of 4-AcO-MET?
A5: Legal status varies by country. For example, it is controlled in Germany and Switzerland, classified as a Class A drug in the UK, and remains unscheduled but subject to potential prosecution in the US.
Q6: Is 4-AcO-MET habit-forming?
A6: No, 4-AcO-MET is not habit-forming, and the desire to use it can decrease with use. Tolerance builds quickly, leading to self-regulation.
Q7: Are there dangerous interactions with other substances?
A7: Yes, potential dangerous interactions exist, especially with lithium, cannabis, stimulants, and tramadol. Independent research is crucial to ensure safe substance combinations.
Q8: How is 4-AcO-MET metabolized in the body?
A8: While it is hypothesized to be hydrolyzed into the free phenolic 4-HO-MET, human studies on its metabolic fate are lacking, leaving aspects of its physiological journey unclear.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics